Engineering and Development

Management and Executive

Chief Financial Officer

Oric Pharmaceuticals Insider Sold Shares Worth $1,053,555, According to a Recent SEC Filing

Oric Pharmaceuticals Insider Sold Shares Worth $1,349,938, According to a Recent SEC Filing

Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald

Oric Pharmaceuticals assumed with a Buy at Guggenheim

Associate Director, Analytical Sciences

ORIC Pharmaceuticals Inc. is a research-driven company dedicated to discovering and developing novel therapies for treatment-resistant cancers. They are seeking a highly motivated analytical research and development scientist to provide analytical leadership on projects and ensure timely delivery of product requirements across all stages of drug development.

Sign up with Google

Sign in with Google